The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Open accessAbstract
There is a great deal of evidence that altered sphingolipid metabolism is associated with fumonisin-induced animal diseases including increased apoptotic and oncotic necrosis, and carcinogenesis in rodent liver and kidney. The biochemical consequences of fumonisin disruption of sphingolipid metabolism most likely to alter cell regulation are increased free sphingoid bases and their 1-phosphates, alterations in complex sphingolipids, and decreased ceramide (CER) biosynthesis. Because free sphingoid bases and CER can induce cell death, the fumonisin inhibition of CER synthase can inhibit cell death induced by CER but promote free sphingoid base-induced cell death. Theoretically, at any time the balance between the intracellular concentration of effectors that protect cells from apoptosis (decreased CER, increased sphingosine 1-phosphate) and those that induce apoptosis (increased CER, free sphingoid bases, altered fatty acids) will determine the cellular response. Because the balance between the rates of apoptosis and proliferation is important in tumorigenesis, cells sensitive to the proliferative effect of decreased CER and increased sphingosine 1-phosphate may be selected to survive and proliferate when free sphingoid base concentration is not growth inhibitory. Conversely, when the increase in free sphingoid bases exceeds a cell's ability to convert sphinganine/sphingosine to dihydroceramide/CER or their sphingoid base 1-phosphate, then free sphingoid bases will accumulate. In this case cells that are sensitive to sphingoid base-induced growth arrest will die and insensitive cells will survive. If the cells selected to die are normal phenotypes and the cells selected to survive are abnormal, then cancer risk will increase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142
Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T., & Merrill, A. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98712-0 · Cited by 1,113
Self-citationBose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., & Kolesnick, R. (1995) · Cell · doi:10.1016/0092-8674(95)90429-8 · Cited by 826
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R. N., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643
Self-citationMerrill, A. H., van Echten, G., Wang, E., & Sandhoff, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74249-5 · Cited by 371
Self-citationPaumen, M. B., Ishida, Y., Muramatsu, M., Yamamoto, M., & Honjo, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3324 · Cited by 349
Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Lavie, Y., Cao, H.-T., Bursten, S. L., Giuliano, A. E., & Cabot, M. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19530 · Cited by 340
Characterization of Ceramide Synthesis
Michel, C., van Echten-Deckert, G., Rother, J., Sandhoff, K., Wang, E., & Merrill, A. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22432 · Cited by 304
Self-citationYoo, H., Norred, W. P., Wang, E., Merrill, A. H., & Riley, R. T. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90090-f · Cited by 200
Self-citationStevens, V. L., & Tang, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.18020 · Cited by 197
Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons
Harel, R., & Futerman, A. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85263-8 · Cited by 183
Xu, J., Yeh, C.-H., Chen, S., He, L., Sensi, S. L., Canzoniero, L. M. T., Choi, D. W., & Hsu, C. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16521 · Cited by 183
Sphingosine 1-phosphate: a prototype of a new class of second messengers
Spiegel, S. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.3.341 · Cited by 173
Fumonisins and other inhibitors of de novo sphingolipid biosynthesis.
Merrill, A. H., Wang, E., Dg, G., et al. (1993) · PubMed · Cited by 169
Self-citationMemon, R. A., Holleran, W. M., Moser, A. H., Seki, T., Uchida, Y., Fuller, J., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.8.1257 · Cited by 165
Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat
Arora, A. S., Jones, B. J., Patel, T. C., Bronk, S. F., & Gores, G. J. (1997) · Hepatology · doi:10.1002/hep.510250428 · Cited by 162
A Regulatory Role for Sphingolipids in Neuronal Growth
Schwarz, A., Rapaport, E., Hirschberg, K., & Futerman, A. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10990 · Cited by 161
Wieder, T., Orfanos, C. E., & Geilen, C. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11025 · Cited by 159
Schmelz, E. M., Dombrink-Kurtzman, M. A., Roberts, P. C., Kozutsumi, Y., Kawasaki, T., & Merrill, A. H. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8356 · Cited by 158
Self-citationAcylation of Naturally Occurring and Synthetic 1-Deoxysphinganines by Ceramide Synthase
Humpf, H., Humpf, H.-U., Schmelz, E.-M., Meredith, F. I., Vesper, H. W., Vales, T. R., Wang, E. L., Menaldino, D. S., Liotta, D. C., & Merrill, A. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19060 · Cited by 151
Self-citationCharacterization of serine palmitoyltransferase activity in Chinese hamster ovary cells
Merrill, A. H. (1983) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(83)90144-3 · Cited by 150
Self-citationSchroeder, J. J., Crane, H. M., Xia, J., Liotta, D. C., & Merrill, A. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41887-4 · Cited by 149
Self-citationHanada, K., Nishijima, M., Kiso, M., Hasegawa, A., Fujita, S., Ogawa, T., & Akamatsu, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35871-x · Cited by 148
Riley, R. T., Wang, E. L., & Merrill, A. H. (1994) · Journal of AOAC International · doi:10.1093/jaoac/77.2.533 · Cited by 144
Self-citationSmith, E. R., & Merrill, A. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18749 · Cited by 140
Self-citationLiao, W., Haimovitz‐Friedman, A., Persaud, R. S., McLoughlin, M., Ehleiter, D., Zhang, N., Gatei, M. H., Lavin, M. F., Kolesnick, R., & FUKS, Z. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17908 · Cited by 135
Yoo, H., Norred, W. P., Showker, J. L., & Riley, R. T. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0119 · Cited by 135
Self-citationSphingolipids as Receptor Modulators: An Overview
Yates, A. J., & Rampersaud, A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09662.x · Cited by 125
Fumonisin Toxicity and Sphingolipid Biosynthesis
Merrill, A. H., Wang, E., Vales, T. R., Smith, E. R., Schroeder, J. J., Menaldino, D. S., Alexander, C., Crane, H. M., Xia, J., Liotta, D. C., et al. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1379-1_25 · Cited by 93
Self-citationStevens, V. L., Nimkar, S., Jamison, W. C. L., et al. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90171-9 · Cited by 86
Effects of intravenous fumonisin B1 in rabbits: Nephrotoxicityxs and sphingolipid alterations
Gumprecht, L. A., Marcucci, A., Weigel, R. M., VESONDER, R. F., Riley, R. T., Showker, J. L., Beasley, V. R., & Haschek, W. M. (1995) · Natural Toxins · doi:10.1002/nt.2620030512 · Cited by 86
Self-citationSandvig, K., Garred, O., van Helvoort, A., Gerrit van, M. E. E. R., & van Deurs, B. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.9.1391 · Cited by 84
Smith, E. R., Jones, P. L., Boss, J. M., & Merrill, A. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5640 · Cited by 79
Self-citationRamljak, D., Calvert, R. J., Wiesenfeld, P. W., Diwan, B. A., Čatipović, B., Marasas, W. F. O., Victor, T. C., Anderson, L. M., & Gelderblom, W. C. A. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.537 · Cited by 76
Nakamura, S., Kozutsumi, Y., Sun, Y., Miyake, Y., Fujita, T., & Kawasaki, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1255 · Cited by 75
Balsinde, J., Balboa, M. A., & Dennis, E. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20373 · Cited by 74
Zanella, J. R. C., & Jones, C. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00034-4 · Cited by 69
Tolleson, W. H., Couch, L. H., Melchior, W. B., Jenkins, G. R., Muskhelishvili, M., Muskhelishvili, L., McGarrity, L. J., Domon, O. E., Morris, S. M., & Howard, P. C. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.5.833 · Cited by 68
Lee, J. Y., LEONHARDT, L. G., & Obeid, L. M. (1998) · Biochemical Journal · doi:10.1042/bj3340457 · Cited by 67
Huang, C., Dickman, M. B., Henderson, G., & Jones, C. (1995) · PubMed · Cited by 63
Ueda, N., Kaushal, G. P., Hong, X., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00008.x · Cited by 61
Gelderblom, W. C. A., Smuts, C. M., Abel, S., Snyman, S. D., Westhuizen, L. V. D., Huber, W., & Swanevelder, S. A. (1997) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(97)00036-7 · Cited by 57
The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation
Cabot, M. C., Han, T.-Y., & Giuliano, A. E. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00744-3 · Cited by 56
Ceramide Triggers Meiotic Cell Cycle Progression in Xenopus Oocytes.
Strum, J. C., Swenson, K. I., Turner, J., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13541 · Cited by 52
Riley, R. T., Showker, J. L., Owens, D. L., et al. (1997) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(97)00015-x · Cited by 45
Self-citationRiley, R. T., Voss, K. A., Norred, W. P., Bacon, C. W., Meredith, F. I., & Sharma, R. P. (1999) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(98)00047-7 · Cited by 36
Self-citationRiley, R. T., & Plattner, R. D. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)11095-x · Cited by 16
Self-citationBioactive Properties of Sphingosine and Structurally Related Compounds
Merrill, A. H., Liotta, D. C., & Riley, R. E. (1996) · Springer eBooks · doi:10.1007/978-1-4899-1361-6_6 · Cited by 14
Self-citation
Cited by
Mycotoxins and human disease: a largely ignored global health issue
Wild, C. P., & Gong, Y. Y. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp264 · Cited by 981
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785
Self-citationMarasas, W. F. O., Riley, R. T., Hendricks, K. A., Stevens, V. L., Sadler, T. W., Gelineau-van Waes, J., Missmer, S. A., Cabrera, J., Torres, O., Gelderblom, W. C. A., et al. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.4.711 · Cited by 604
Self-citationZheng, W., Kollmeyer, J., Symolon, H., Momin, A., Munter, E., Wang, E., Kelly, S., Allegood, J. C., Liu, Y., Peng, Q., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.009 · Cited by 560
Self-citationExposure to Fumonisins and the Occurrence of Neural Tube Defects along the Texas–Mexico Border
Missmer, S. A., Suarez, L., Felkner, M., Wang, E., Merrill, A. H., Rothman, K. J., & Hendricks, K. A. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8221 · Cited by 514
Self-citation
Metadata
- Authors
- Riley, R. T., Enongene, E., Voss, K. A., Norred, W. P., Meredith, F. I., Sharma, R. P., Spitsbergen, J., Williams, D. E., Carlson, D. B., & Merrill, A. H.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2001-05
- Volume
- 109
- Issue
- suppl 2
- Pages
- 301-308
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2036039480
- Cited by
- 258
- References
- 50
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.